n(6)-carboxymethyllysine has been researched along with eprosartan in 1 studies
Studies (n(6)-carboxymethyllysine) | Trials (n(6)-carboxymethyllysine) | Recent Studies (post-2010) (n(6)-carboxymethyllysine) | Studies (eprosartan) | Trials (eprosartan) | Recent Studies (post-2010) (eprosartan) |
---|---|---|---|---|---|
803 | 44 | 365 | 297 | 83 | 49 |
Protein | Taxonomy | n(6)-carboxymethyllysine (IC50) | eprosartan (IC50) |
---|---|---|---|
ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | 6.65 | |
Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.1244 | |
Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.1244 | |
Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.1217 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hartog, JW; Jaarsma, W; Miyata, T; Plokker, HW; Schalkwijk, CG; Smit, AJ; van de Wal, RM; van Veldhuisen, DJ; van Wijk, LM; Voors, AA | 1 |
1 trial(s) available for n(6)-carboxymethyllysine and eprosartan
Article | Year |
---|---|
Advanced glycation end-products, anti-hypertensive treatment and diastolic function in patients with hypertension and diastolic dysfunction.
Topics: Acrylates; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Diastole; Female; Glycation End Products, Advanced; Humans; Hypertension; Imidazoles; Linear Models; Lysine; Male; Middle Aged; Multivariate Analysis; Netherlands; Skin; Statistics as Topic; Statistics, Nonparametric; Stroke Volume; Thiophenes; Ventricular Function, Left | 2010 |